Adiponectin improves insulin sensitivity, limits inflammation, and supports normal ovarian signaling
At the same time, if verified peptide formulations were ultimately shown to enhance soft-tissue recovery without increasing infection risk, the clinical relevance for TJA would be substantial, underscoring the importance of rigorous clinical investigation rather than informal adoption
It is not approved by the FDA or any other regulatory body for human or veterinary use, and nothing in this guide constitutes guidance for human administration
How It Works BPC-157 (Body Protection Compound-157) is a gastric pentadecapeptide that promotes tissue healing through multiple mechanisms: upregulation of growth factor signaling (VEGF, FGF), promotion of angiogenesis (new blood vessel formation), and activation of cellular repair pathways
While effective, its pigment-inducing capacity limits its use in research
Plug in the default to see what each dose delivers